Contrast-induced nephropathy is defined as a serum creatinine level that increases by at least 25% or is 44.2 μmol/L greater than baseline within three days of receiving contrast medium intravascularly in the absence of another cause.
1 Contrastinduced nephropathy is usually selflimiting; at worst, it can make the patient permanently dependent on hemodialysis or can result in death. The possibility of renal dysfunction should be considered in a patient with one or more of the following characteristics: 
Consider alternative imaging tests
In a patient with moderate or severe renal dysfunction, alternative imaging tests may yield the same information without the risks. Other options include computed tomography without contrast medium, ultrasonography and magnetic resonance imaging. • hydration or volume expansion, ideally with intravenous 0.9% saline solution or isotonic bicarbonate solution; • administration of acetylcysteine (600 mg orally twice daily) the day before and the day of the test (although there is some disagreement in the literature about its usefulness); • reduction of the amount of contrast medium, and • no additional administration of contrast medium for at least 72 hours. A patient at increased risk of contrast-induced nephropathy should have his or her serum creatinine level measured again 48-72 hours after receiving contrast medium intravascularly. If renal function does not return to baseline, referral to a nephrologist may be necessary. DOI:10.1503/cmaj.090372
